GlassScriptPhysician profile
Jeremy Maxwell
NPI 1548839244
$613.02
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $147 · 2022: $160 · 2023: $113 · 2024: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $114.35 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $84.92 | 2021 | |
| Novo Nordisk INC | $72.19 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $64.73 | 2021-2023 | Pifeltro, Delstrigo, Dificid |
| Teva Pharmaceuticals USA, INC. | $51.11 | 2022-2023 | Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $47.40 | 2024 | Airsupra, Breztri |
| Medline Industries LP | $35.31 | 2022 | |
| Sanofi-Aventis U.S. LLC | $24.84 | 2024 | |
| Ironshore Pharmaceuticals INC. | $22.86 | 2022 | |
| Csl Behring | $18.23 | 2023 | Hizentra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.95 | 2024 | Xifaxan, Trulance |
| Amgen INC. | $16.59 | 2024 | Prolia, Evenity |
| Exact Sciences Corporation | $15.80 | 2024 | Cologuard Collection Kit |
| Neurelis, INC. | $13.92 | 2022 | |
| Kci USA, INC. | $13.82 | 2023 | Prevena, V.A.C.Instill |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.